Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate

被引:37
作者
Jin, Junfei [1 ,2 ,3 ]
Liao, Weijia [1 ]
Yao, Wenmin [1 ]
Zhu, Rongping [1 ]
Li, Yulan [1 ,2 ,3 ]
He, Songqing [1 ,2 ]
机构
[1] Affiliated Hosp Guilin Med Univ, Lab Hepatobiliary & Pancreat Surg, Guilin 541001, Guangxi, Peoples R China
[2] Guilin Med Univ, Guangxi Key Lab Mol Med Liver Injury & Repair, Guilin 541001, Guangxi, Peoples R China
[3] Guilin Med Univ, China USA Lipids Hlth & Dis Res Ctr, Guilin 541001, Guangxi, Peoples R China
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
基金
中国国家自然科学基金;
关键词
HEPATOCELLULAR-CARCINOMA; 1B10; AKR1B10; EXPRESSION; OVEREXPRESSION; B10; IDENTIFICATION; ASSOCIATION; PROGNOSIS; SURVIVAL; GENE;
D O I
10.1038/srep22746
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
AKR1B10 is involved in hepatocarcinogenesis via modulation of fatty acid and lipid synthesis. AKR1B10 inhibition results in apoptosis of tumor cells whose lipids, especially phospholipids, were decreased by over 50%, suggesting involvement of phospholipids like sphingosine-1-phosphate (S1P) in AKR1B10's oncogenic function. Using a co-culture system, we found that co-culture of QSG-7701 (human hepatocyte) with HepG2 (hepatoma cell line) increases QSG-7701's proliferation, in which AKR1B10-S1P signaling plays a pivotal role. Consistent with previous findings, AKR1B10 mRNA and protein levels were higher in primary hepatocellular carcinoma (PHC) tissues than in peri-tumor tissues. Interestingly, the level of S1P was also higher in PHC tissues than in peri-tumor tissues. After analyzing the correlation between AKR1B10 mRNA expression in PHC tissues and the clinical data, we found that AKR1B10 mRNA expression was associated with serum alpha-fetoprotein (AFP), tumor-node-metastasis (TNM) stage, and lymph node metastasis, but not with other clinicopathologic variables. A higher AKR1B10 mRNA expression level is related to a shorter DFS (disease free survival) and OS (overall survival), serving as an independent predictor of DFS and OS in PHC patients with surgical resection.
引用
收藏
页数:11
相关论文
共 25 条
[1]   Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].
Altekruse, Sean F. ;
McGlynn, Katherine A. ;
Reichman, Marsha E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491
[2]   Cancer biomarker AKR1B10 and carbonyl metabolism [J].
Balendiran, Ganesaratnam K. ;
Martin, Hans-Joerg ;
El-Hawari, Yasser ;
Maser, Edmund .
CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 178 (1-3) :134-137
[3]   Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma [J].
Breton, Jean ;
Gage, Matthew C. ;
Hay, Alastair W. ;
Keen, Jeffrey N. ;
Wild, Christopher P. ;
Donnellan, Clare ;
Findlay, John B. C. ;
Hardie, Laura J. .
JOURNAL OF PROTEOME RESEARCH, 2008, 7 (05) :1953-1962
[4]   Identification and characterization of a novel human aldose reductase-like gene [J].
Cao, DL ;
Fan, ST ;
Chung, SSM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11429-11435
[5]   Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma [J].
Chung, Yeon Tae ;
Matkowskyj, Kristina A. ;
Li, Haonan ;
Bai, Han ;
Zhang, Wanying ;
Tsao, Ming-Sound ;
Liao, Jie ;
Yang, Guang-Yu .
MODERN PATHOLOGY, 2012, 25 (05) :758-766
[6]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[7]   Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas [J].
Fukumoto, S ;
Yamauchi, N ;
Moriguchi, H ;
Hippo, Y ;
Watanabe, A ;
Shibahara, J ;
Taniguchi, H ;
Ishikawa, S ;
Ito, H ;
Yamamoto, S ;
Iwanari, H ;
Hironaka, M ;
Ishikawa, Y ;
Niki, T ;
Sohara, Y ;
Kodama, T ;
Nishimura, M ;
Fukayama, M ;
Dosaka-Akita, H ;
Aburatani, H .
CLINICAL CANCER RESEARCH, 2005, 11 (05) :1776-1785
[8]   High Expression of Aldo-Keto Reductase 1B10 Is an Independent Predictor of Favorable Prognosis in Patients with Hepatocellular Carcinoma [J].
Ha, Sang Yun ;
Song, Dae Hyun ;
Lee, Jae Jun ;
Lee, Hyun Woo ;
Cho, Soo Youn ;
Park, Cheol-Keun .
GUT AND LIVER, 2014, 8 (06) :648-654
[9]   Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours [J].
Heringlake, Stefan ;
Hofdmann, Michael ;
Fiebeler, Anette ;
Manns, Michael P. ;
Schmiegel, Wolff ;
Tannapfel, Andrea .
JOURNAL OF HEPATOLOGY, 2010, 52 (02) :220-227
[10]   Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection [J].
Jin, Junfei ;
Zhu, Pengpeng ;
Liao, Yan ;
Li, Jun ;
Liao, Weijia ;
He, Songqing .
ONCOTARGET, 2015, 6 (22) :19217-19227